2853
Eosin B Solution
0.1% aqueous solution
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| Tamaño de envase | SKU | Disponibilidad | Precio |
|---|
Acerca de este artículo
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleQuality Level
form
solution
IVD
for in vitro diagnostic use
concentration
0.1%
application(s)
hematology
histology
storage temp.
room temp
SMILES string
[Na+].[Na+].[O-]C(=O)c1ccccc1C2=C3C=C(C(=O)C(Br)=C3Oc4c(Br)c([O-])c(cc24)[N+]([O-])=O)[N+]([O-])=O
InChI
1S/C20H8Br2N2O9.2Na/c21-14-16(25)11(23(29)30)5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(24(31)32)17(26)15(22)19(10)33-18(9)14;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2
InChI key
GYYTYUGGVBYJHE-UHFFFAOYSA-L
Application
Used as a counterstain in Sigma Procedure 285 for Fetal Hemoglobin.
Other Notes
Eosin B, 0.1%, aqueous solution. Sodium azide, 0.1% added as preservative
Clase de almacenamiento
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Nilay S Sethi et al.
Nature genetics, 52(2), 219-230 (2020-02-07)
Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study
Lucía Margarita Valenzuela-Salas et al.
Pharmaceutics, 13(1) (2021-01-13)
Nanomaterials quickly evolve to produce safe and effective biomedical alternatives, mainly silver nanoparticles (AgNPs). The AgNPs' antibacterial, antiviral, and antitumor properties convert them into a recurrent scaffold to produce new treatment options. This work reported the full characterization of a
Rocky Strollo et al.
Diabetologia, 58(12), 2851-2860 (2015-09-10)
Insulin is the most specific beta cell antigen and a potential primary autoantigen in type 1 diabetes. Insulin autoantibodies (IAAs) are the earliest marker of beta cell autoimmunity; however, only slightly more than 50% of children and even fewer adults
Número de artículo de comercio global
| SKU | GTIN |
|---|---|
| 1372601000 | 04065267204468 |
| 1372769025 | 04065267205113 |
| 1372609025 | 04065267204482 |
| 1372609010 | 04065267204475 |
| 1032520250 | 04022536040844 |
| 391335-1KG | 04055977190090 |
| 391335-100GM | 04055977190106 |
| RDD013-500G | 04061836828431 |
| RDD013-100G | 04061836828417 |
| 14879-100G-F | 04061838738059 |
| B7535-25G | 04061833441909 |
| B7535-500G | 04061833441916 |
| B9754-1KG | 04061833443941 |
| B7535-100G | 04061833441893 |
| B9754-500G | 04061833443965 |
| B4429-1KG | 04061835542857 |
| B4429-100G | 04061833429655 |
| 1372600003 | 04065267204444 |
| 1372761000 | 04065267205090 |
| 1372600100 | 04065267204451 |
| 1372760100 | 04065267205083 |
| 1372760003 | 04065267205076 |